Denosumab
5 NDCs across 2 manufacturers|0 Generic,5 Brand
Denosumab is used to treat postmenopausal osteoporosis and osteoporotic fractures, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $828 million on Denosumab across 469,000 claims for 288,000 beneficiaries.
Denosumab is available as 5 NDCs from 2 manufacturers (0 generic, 5 brand), with NADAC prices from $1537.25 to $2001.52 per ML — a 30% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
5
0G / 5B
Manufacturers
2
competing in market
Price Spread
$1537.25 – $2001.52
per ML
7d Activity
avg +0.0% WoW · of 5 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
2 manufacturers producing DENOSUMAB
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
XGEVA 120 MG/1.7 ML VIAL | $2001.5168 per ML | — |
XGEVA 120 MG/1.7 ML VIAL | $2001.5168 per ML | — |
PROLIA 60 MG/ML SYRINGE | $1863.7230 per ML | 0.00% |
PROLIA 60 MG/ML SYRINGE | $1863.7230 per ML | 0.00% |
JUBBONTI 60 MG/ML SYRINGE | $1537.2474 per ML | 0.00% |
Frequently Asked Questions
What is Denosumab used to treat?
Denosumab is used to treat postmenopausal osteoporosis and osteoporotic fractures, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Denosumab?
In 2024, Medicare Part D spent $828 million on Denosumab across 469,000 claims for 288,000 beneficiaries.
How many Denosumab products are on the market?
The Denosumab drug market contains 5 NDCs from 2 manufacturers — 0 generic and 5 brand products.
What is the price range for Denosumab?
NADAC reference prices for Denosumab range from $1537.2474 to $2001.5168 per ML — a 30% difference between cheapest and most expensive.
Which manufacturers make Denosumab?
2 manufacturers list Denosumab in NADAC. Ranked by number of NDCs, the largest are Amgen Inc. (4), Sandoz Inc. (1).
How has the price of Denosumab changed recently?
Over the past 7 days, 0 Denosumab NDCs rose and 0 fell, with a market-wide average change of +0.0%.